Published in Curr Opin Rheumatol on November 01, 2015
Genetics in inclusion body myositis. Curr Opin Rheumatol (2017) 0.75
Genome-wide association study reveals genetic risk underlying Parkinson's disease. Nat Genet (2009) 10.34
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol (2012) 5.18
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease. Brain (2009) 4.01
Characterization of PLA2G6 as a locus for dystonia-parkinsonism. Ann Neurol (2009) 3.62
SNCA variants are associated with increased risk for multiple system atrophy. Ann Neurol (2009) 3.55
Parkinson's disease induced pluripotent stem cells with triplication of the α-synuclein locus. Nat Commun (2011) 3.23
A common polymorphism in the brain-derived neurotrophic factor gene (BDNF) modulates human cortical plasticity and the response to rTMS. J Physiol (2008) 3.00
Multicentre search for genetic susceptibility loci in sporadic epilepsy syndrome and seizure types: a case-control study. Lancet Neurol (2007) 2.88
Defective FA2H leads to a novel form of neurodegeneration with brain iron accumulation (NBIA). Ann Neurol (2010) 2.48
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation. Mov Disord (2010) 2.47
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C. Nat Genet (2009) 2.32
Charcot-Marie-Tooth disease: frequency of genetic subtypes and guidelines for genetic testing. J Neurol Neurosurg Psychiatry (2012) 2.20
Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. Cell Rep (2011) 2.17
Deletion at ITPR1 underlies ataxia in mice and spinocerebellar ataxia 15 in humans. PLoS Genet (2007) 2.09
Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. Am J Hum Genet (2013) 2.09
Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54. Am J Hum Genet (2010) 2.08
Dysfunction of the brain calcium channel CaV2.1 in absence epilepsy and episodic ataxia. Brain (2004) 2.04
Identical twins with Leucine rich repeat kinase type 2 mutations discordant for Parkinson's disease. Mov Disord (2012) 2.02
Hereditary sensory neuropathy type 1 is caused by the accumulation of two neurotoxic sphingolipids. J Biol Chem (2010) 1.93
Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2. Brain (2013) 1.93
Mutations in the autoregulatory domain of β-tubulin 4a cause hereditary dystonia. Ann Neurol (2013) 1.90
Clinical implications of genetic advances in Charcot-Marie-Tooth disease. Nat Rev Neurol (2013) 1.88
α-Synucleinopathy associated with G51D SNCA mutation: a link between Parkinson's disease and multiple system atrophy? Acta Neuropathol (2013) 1.75
Towards a complete resolution of the genetic architecture of disease. Trends Genet (2010) 1.75
A novel α-synuclein missense mutation in Parkinson disease. Neurology (2013) 1.74
KIF1A, an axonal transporter of synaptic vesicles, is mutated in hereditary sensory and autonomic neuropathy type 2. Am J Hum Genet (2011) 1.66
Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail (2010) 1.66
Widespread Lewy body and tau accumulation in childhood and adult onset dystonia-parkinsonism cases with PLA2G6 mutations. Neurobiol Aging (2010) 1.56
Early-onset L-dopa-responsive parkinsonism with pyramidal signs due to ATP13A2, PLA2G6, FBXO7 and spatacsin mutations. Mov Disord (2010) 1.56
Presenilin 1 mutation in an african american family presenting with atypical Alzheimer dementia. Arch Neurol (2003) 1.55
Clinical, genetic, neurophysiological and functional study of new mutations in episodic ataxia type 1. J Neurol Neurosurg Psychiatry (2013) 1.55
Mutations in BICD2 cause dominant congenital spinal muscular atrophy and hereditary spastic paraplegia. Am J Hum Genet (2013) 1.51
Dominant mutations in the cation channel gene transient receptor potential vanilloid 4 cause an unusual spectrum of neuropathies. Brain (2010) 1.51
Clinical features of childhood-onset paroxysmal kinesigenic dyskinesia with PRRT2 gene mutations. Dev Med Child Neurol (2013) 1.51
Exome sequencing reveals riboflavin transporter mutations as a cause of motor neuron disease. Brain (2012) 1.50
Pathogenic VCP mutations induce mitochondrial uncoupling and reduced ATP levels. Neuron (2013) 1.45
Mutation of FA2H underlies a complicated form of hereditary spastic paraplegia (SPG35). Hum Mutat (2010) 1.44
PRRT2 gene mutations: from paroxysmal dyskinesia to episodic ataxia and hemiplegic migraine. Neurology (2012) 1.44
Novel insights into the pathomechanisms of skeletal muscle channelopathies. Curr Neurol Neurosci Rep (2012) 1.43
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trial. JAMA (2012) 1.40
Understanding differences between phylogenetic and pedigree-derived mtDNA mutation rate: a model using families from the Azores Islands (Portugal). Mol Biol Evol (2005) 1.38
Recent advances in the genetics of cerebellar ataxias. Curr Neurol Neurosci Rep (2012) 1.37
Episodic ataxia type 1: a neuronal potassium channelopathy. Neurotherapeutics (2007) 1.36
Exome sequencing in an SCA14 family demonstrates its utility in diagnosing heterogeneous diseases. Neurology (2012) 1.33
Adenosine monophosphate-activated protein kinase disease mimicks hypertrophic cardiomyopathy and Wolff-Parkinson-White syndrome: natural history. J Am Coll Cardiol (2005) 1.32
Neuronal P/Q-type calcium channel dysfunction in inherited disorders of the CNS. Nat Rev Neurol (2012) 1.28
Skeletal muscle channelopathies: nondystrophic myotonias and periodic paralysis. Curr Opin Neurol (2010) 1.26
The UK MRC Mitochondrial Disease Patient Cohort Study: clinical phenotypes associated with the m.3243A>G mutation--implications for diagnosis and management. J Neurol Neurosurg Psychiatry (2013) 1.23
Mutations in GBA2 cause autosomal-recessive cerebellar ataxia with spasticity. Am J Hum Genet (2013) 1.22
Exome sequencing in Brown-Vialetto-van Laere syndrome. Am J Hum Genet (2010) 1.22
The Parkinson's disease-linked proteins Fbxo7 and Parkin interact to mediate mitophagy. Nat Neurosci (2013) 1.19
Episodic ataxia type 1 mutations differentially affect neuronal excitability and transmitter release. Dis Model Mech (2009) 1.16
Progressive neurological disease induced by tacrolimus in a renal transplant recipient: case presentation. BMC Nephrol (2006) 1.15
Glucocerebrosidase mutations confer a greater risk of dementia during Parkinson's disease course. Mov Disord (2011) 1.15
Quantitative muscle MRI as an assessment tool for monitoring disease progression in LGMD2I: a multicentre longitudinal study. PLoS One (2013) 1.14
Mutant COQ2 in multiple-system atrophy. N Engl J Med (2014) 1.14
Reliability and accuracy of skeletal muscle imaging in limb-girdle muscular dystrophies. Neurology (2013) 1.11
Genetic dysfunction of MT-ATP6 causes axonal Charcot-Marie-Tooth disease. Neurology (2012) 1.11
Human ataxias: a genetic dissection of inositol triphosphate receptor (ITPR1)-dependent signaling. Trends Neurosci (2010) 1.10
Concomitant progressive supranuclear palsy and chronic traumatic encephalopathy in a boxer. Acta Neuropathol Commun (2014) 1.09
Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry (2013) 1.09
A novel NGF mutation clarifies the molecular mechanism and extends the phenotypic spectrum of the HSAN5 neuropathy. J Med Genet (2010) 1.08
Severe infantile neuropathy with diaphragmatic weakness and its relationship to SMARD1. Brain (2003) 1.07
The MAPT p.A152T variant is a risk factor associated with tauopathies with atypical clinical and neuropathological features. Neurobiol Aging (2012) 1.07
Mitochondrial disease: mutations and mechanisms. Neurochem Res (2004) 1.07
Hereditary sensory neuropathies. Curr Opin Neurol (2004) 1.06
C9orf72 expansions are the most common genetic cause of Huntington disease phenocopies. Neurology (2013) 1.06
Novel C12orf65 mutations in patients with axonal neuropathy and optic atrophy. J Neurol Neurosurg Psychiatry (2013) 1.06
Nerve excitability studies characterize Kv1.1 fast potassium channel dysfunction in patients with episodic ataxia type 1. Brain (2010) 1.05
Validation of next-generation sequencing technologies in genetic diagnosis of dementia. Neurobiol Aging (2013) 1.05
Is the mitochondrial complex I ND5 gene a hot-spot for MELAS causing mutations? Ann Neurol (2003) 1.04
Mitochondrial ND5 gene variation associated with encephalomyopathy and mitochondrial ATP consumption. J Biol Chem (2007) 1.04
Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo. Clin Neurophysiol (2009) 1.03
Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies. Ann Neurol (2011) 1.02
Genetic neuromuscular disease. J Neurol Neurosurg Psychiatry (2002) 1.01
Genetic variability at the PARK16 locus. Eur J Hum Genet (2010) 1.01
α-Synuclein mutations cluster around a putative protein loop. Neurosci Lett (2013) 1.00
THAP1 mutations and dystonia phenotypes: genotype phenotype correlations. Mov Disord (2012) 1.00
Is it really myositis? A consideration of the differential diagnosis. Curr Opin Rheumatol (2004) 1.00
c-Jun expression in human neuropathies: a pilot study. J Peripher Nerv Syst (2011) 1.00
Alpha-synuclein mRNA expression in oligodendrocytes in MSA. Glia (2014) 0.99
The inherited ataxias: genetic heterogeneity, mutation databases, and future directions in research and clinical diagnostics. Hum Mutat (2012) 0.99
Genetic and functional characterisation of the P/Q calcium channel in episodic ataxia with epilepsy. J Physiol (2010) 0.99
Paediatric single mitochondrial DNA deletion disorders: an overlapping spectrum of disease. J Inherit Metab Dis (2014) 0.99
Rapidly progressive asymmetrical weakness in Charcot-Marie-Tooth disease type 4J resembles chronic inflammatory demyelinating polyneuropathy. Neuromuscul Disord (2013) 0.98
Neurological disorders caused by inherited ion-channel mutations. Lancet Neurol (2002) 0.97
Hereditary sensory neuropathy is caused by a mutation in the delta subunit of the cytosolic chaperonin-containing t-complex peptide-1 (Cct4 ) gene. Hum Mol Genet (2003) 0.97
Adults with RRM2B-related mitochondrial disease have distinct clinical and molecular characteristics. Brain (2012) 0.96
Genetic risk factors for intracranial aneurysms: a meta-analysis in more than 116,000 individuals. Neurology (2013) 0.96
Sporadic inclusion body myositis: the genetic contributions to the pathogenesis. Orphanet J Rare Dis (2014) 0.95
High frequency of the expanded C9ORF72 hexanucleotide repeat in familial and sporadic Greek ALS patients. Neurobiol Aging (2012) 0.95
Somatic alpha-synuclein mutations in Parkinson's disease: hypothesis and preliminary data. Mov Disord (2013) 0.94
Clinical features, with video documentation, of the original familial lewy body parkinsonism caused by α-synuclein triplication (Iowa kindred). Mov Disord (2011) 0.93
Variable K(+) channel subunit dysfunction in inherited mutations of KCNA1. J Physiol (2002) 0.93
Common pathogenic pathways in melanoma and Parkinson disease. Neurology (2010) 0.92
Kearns-Sayre syndrome caused by defective R1/p53R2 assembly. J Med Genet (2011) 0.92
The phenotypic spectrum of DYT24 due to ANO3 mutations. Mov Disord (2014) 0.92